Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 50268-191

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 50268-191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

50 (191 15)

50 (191 15)
Packaging label for Cyclobenzaprine Hydrochloride Tablets, USP 10 mg, film-coated oral tablets. The label shows a unit dose package of 50 tablets (5 x 10). It is labeled for prescription use only and includes storage instructions and manufacturer information for AvPAK. The label also displays the product NDC 50268-191-15 and a barcode.*
FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 01)

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 01)
Chemical structure of Cyclobenzaprine Hydrochloride showing its molecular configuration with aromatic rings and side chains, including the hydrochloride component.*
FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 02)

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 02)
A data table comparing the incidence of side effects — drowsiness, dry mouth, fatigue, and headache — among subjects taking Cyclobenzaprine HCl tablets at 5 mg and 10 mg doses versus placebo, including the sample sizes for each group.*
FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 03)

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 03)
A data table comparing the reported incidence percentages of drowsiness, dry mouth, and dizziness in clinical studies versus a surveillance program for Cyclobenzaprine Hydrochloride 10 mg tablets. The table shows higher incidence rates in clinical studies compared to the surveillance program across all three side effects.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.